Literature DB >> 6486725

Induction of complete and irreversible damage to malignant glioma cells by L-2,4 diaminobutyric acid.

G Ronquist, B Westermark, R Hugosson.   

Abstract

L-2,4 Diaminobutyric acid (DAB), a non-physiological amino acid, induced an irreversible injury to human malignant glioma cells when incubated for 24h at an amino acid concentration of 6 mmol/l at 37 degrees C. The same treatment of the human glia cells did not result in any cellular damage; not even a concentration as high as 20 mmol/l of the amino acid under the same incubation conditions did affect these cells. However, a further increase in amino acid concentration above that level resulted in a gradual loss of viability among the human glia cells. An experimentally induced rat glioma cell line was also affected by DAB, although displaying less sensitivity than the human glioma cells, and complete cellular destruction was achieved at 16 mmol/l of DAB, i.e. well below the critical concentration for human glia cells. The destructive effect by DAB was pH-sensitive. The N-methylated analogue of a - amino-isobutyric acid exerted a specific inhibitory action on DAB activity, but other amino acids were also inhibitory to various degrees at higher concentrations. Future clinical applications in the treatment of malignant brain tumours in man are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6486725

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB).

Authors:  A Tommy Bergenheim; Michael Roslin; Urban Ungerstedt; Anders Waldenström; Roger Henriksson; Gunnar Ronquist
Journal:  J Neurooncol       Date:  2006-06-14       Impact factor: 4.130

2.  The cytolytic effect of L-2,4 diaminobutyric acid with malignant glioma cells and fibroblasts.

Authors:  L Panasci; A McQuillan; W Feindel
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Treatment of malignant glioma by a new therapeutic principle.

Authors:  G Ronquist; R Hugosson; U Sjölander; U Ungerstedt
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

Review 4.  Membrane transport properties of L-2,4-diaminobutyrate revisited.

Authors:  H N Christensen; G Ronquist
Journal:  J Membr Biol       Date:  1992-04       Impact factor: 1.843

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.